Clinical evaluation of the efficacy, acceptability and tolerability of fenofibrate, a second generation fibric acid derivative, in treatment of patients with hypercholesterolemia dn hypertriglyceridemia
Dr Tai, Yau Ting (Principal investigator)
Dr Fong (Co-Investigator)
Professor Lau Chu Pak (Co-Investigator)
Other Funding Scheme
This constitutes part of an international multicentre study to evaluate the role of HMG CoA reductase inhibitors in the treatment of patients with hypercholestarolemia.